Marc Tessier-Lavigne

Marc Tessier-Lavigne is the founder of Renovis, Inc., founded in 2000.
Dr. Tessier-Lavigne was the founder of Denali Therapeutics, Inc., founded in 2013, and served as Independent Director from 2016 to 2026.
Dr. Tessier-Lavigne is the founder of Xaira Therapeutics, Inc., founded in 2023, and holds the titles of Chairman & Chief Executive Officer since 2024.
Current jobs include Director at the Federal Reserve Bank of New York, Director at the Stanford Alumni Association, Director at the Bay Area Council Economic Institute, Director at The Rockefeller Archive Center, Member of The Royal Society, Member of the National Academy of Sciences, Member of the National Academy of Medicine (United States), Member of the American Philosophical Society, Member of the Royal Society of Canada, and Professor at Stanford University since 2023.
Former jobs include Chairman at Agios Pharmaceuticals, Inc. from 2015 to 2016, Independent Director at Pfizer Inc. from 2012 to 2015, Independent Director at Regeneron Pharmaceuticals, Inc. from 2011 to 2023, Director at The Aaron Diamond AIDS Research Center, Independent Director at Juno Therapeutics, Inc. from 2014 to 2016, Chief Scientific Officer & Executive VP-Research at Genentech, Inc. from 2010 to 2011, Professor at The University of California, San Francisco from 1991 to 2001, and President, Trustee & Professor at The Rockefeller University from 2013 to 2016.
Education includes undergraduate degrees from McGill University in 1980 and the University of Oxford in 1983, and a doctorate from University College London in 1987.